Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.

The pharmacogenomics journal - 1 Feb 2009

Nelson M R, Bacanu S-A, Mosteller M, Li L, Bowman C E, Roses A D, Lai E H, Ehm M G

Abstract excerpt

Adverse drug reactions (ADRs) have a major impact on patients, physicians, health care providers, regulatory agencies and pharmaceutical companies. Identifying the genetic contributions to ADR risk may lead to a better understanding of the underlying mechanisms, identification of patients at risk and a decrease in the number of events. Technological advances have made the routine monitoring and investigation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Dideoxynucleosides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Hypersensitivity

Share to Drug-Related Side Effects and Adverse Reactions

Share to Genome, Human

Share to HLA-B Antigens

Share to Pharmacogenetics

Source

Identifiers

PMID: 18301416
DOI: 10.1038/tpj.2008.4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.PMID 18301416Read ↗

Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an example.Semantic proximity Read ↗

Genomics of Adverse Drug Reactions.Semantic proximity Read ↗

Insights from genome-wide association studies of drug response.Semantic proximity Read ↗

Genotyping for severe drug hypersensitivity.Semantic proximity Read ↗

Digging up the human genome: current progress in deciphering adverse drug reactions.Semantic proximity Read ↗

A genomic-led strategy to anticipate drug safety effectsSemantic proximity Read ↗

Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.Semantic proximity Read ↗

A genomic-led strategy to anticipate drug safety effects.Semantic proximity Read ↗

Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.Semantic proximity Read ↗

Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.Semantic proximity Read ↗

Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.Semantic proximity Read ↗

EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.